Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Langley, R G
- Blauvelt, A 5
- Reich, K 5
- Gordon, K B 3
- Lebwohl, M 3
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
-
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
-
-
Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis
2019 - Forschungsinformationssystem des UKE